
Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development and commercialization of plant-derived medical and pharmaceutical cannabinoid-based products, has entered into an exclusive license and supply agreement with an established South American pharmaceutical company to commercialize up to four of Avicanna’s proprietary cannabinoid-based pharmaceutical preparations.
